Sheryl A. Lazarus
University of California, Davis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sheryl A. Lazarus.
Journal of Nutrition | 2000
John F. Hammerstone; Sheryl A. Lazarus; Harold H. Schmitz
Procyanidins are a subclass of flavonoids found in commonly consumed foods that have attracted increasing attention due to their potential health benefits. However, little is known regarding their dietary intake levels because detailed quantitative information on the procyanidin profiles present in many food products is lacking. Therefore, the procyanidin content of red wine, chocolate, cranberry juice and four varieties of apples has been determined. On average, chocolate and apples contained the largest procyanidin content per serving (164.7 and 147.1 mg, respectively) compared with red wine and cranberry juice (22.0 and 31.9 mg, respectively). However, the procyanidin content varied greatly between apple samples (12.3-252.4 mg/serving) with the highest amounts on average observed for the Red Delicious (207.7 mg/serving) and Granny Smith (183.3 mg/serving) varieties and the lowest amounts in the Golden Delicious (92.5 mg/serving) and McIntosh (105.0 mg/serving) varieties. The compositional data reported herein are important for the initial understanding of which foods contribute most to the dietary intake of procyanidins and may be used to compile a database necessary to infer epidemiological relationships to health and disease.
Clinical & Developmental Immunology | 2005
Cesar G. Fraga; Lucas Actis-Goretta; Javier I. Ottaviani; Fernando Carrasquedo; Silvina B. Lotito; Sheryl A. Lazarus; Harold H. Schmitz; Carl L. Keen
The consumption of a diet rich in certain flavonoids, including the flavanol sub-class, has been associated with a reduced risk for vascular disease. We evaluated the effects of the regular consumption (14 d) of a flavanol-containing milk chocolate (FCMC) or cocoa butter chocolate (CBC) on variables related to vascular disease risk, oxidative stress and physical activity. Twenty-eight free-living, young (18–20 years old) male soccer players consumed daily 105 g of FCMC (168 mg of flavanols) or CBC (<5 mg of flavanols), as part of their normal diet. The consumption of FCMC was significantly associated with a decrease in diastolic blood pressure (-5 mm Hg), mean blood pressure (-5 mm Hg), plasma cholesterol (-11%), LDL-cholesterol (-15%), malondialdehyde (-12%), urate (-11%) and lactate dehydrogenase (LDH) activity (-11%), and an increase in vitamin E/cholesterol (+12%). No relevant changes in these variables were associated with CBC consumption. No changes in the plasma levels of (-)-epicatechin were observed following analysis of fasting blood samples. In conclusion, FCMC consumption was associated with changes in several variables often associated with cardiovascular health and oxidant stress. The presence of significant quantities of flavanols in FCMC is likely to have been one of the contributing factors to these results.
Seminars in Thrombosis and Hemostasis | 2011
Melinda Phang; Sheryl A. Lazarus; Lisa Wood; Manohar L. Garg
An increased prothrombotic state is a major risk factor for the development of heart attacks, strokes, and venous thromboembolism. Platelet activation and aggregation play an important role in determining a prothrombotic state. Although pharmaceutical agents such as aspirin, heparin, and warfarin are able to reduce prothrombotic tendency, long-term drug treatment may produce a variety of side effects, including bleeding. Diet is generally recognized to be significantly involved in modifying the individual risk for the development of thrombotic diseases, although its influence during the treatment of these disorders is probably less important. Dietary intervention has proven effective in lowering serum lipid levels, which are otherwise essential elements in the pathogenesis of cardiovascular disease. Likewise, certain dietary components have also been proven effective in decreasing platelet activation through various mechanisms and therefore may contribute to attenuating the future risk of thrombosis. This article provides an up-to-date review of the role of nutrient and nonnutrient supplements on platelet aggregation and risk of thrombosis.
The American Journal of Clinical Nutrition | 2002
Roberta R. Holt; Sheryl A. Lazarus; M. Cameron Sullards; Qin Yan Zhu; Derek D. Schramm; John F. Hammerstone; Cesar G. Fraga; Harold H. Schmitz; Carl L. Keen
Journal of Agricultural and Food Chemistry | 1999
John F. Hammerstone; Sheryl A. Lazarus; Alyson E. Mitchell; Robert B. Rucker; Harold H. Schmitz
Journal of Agricultural and Food Chemistry | 1999
Gary E. Adamson; Sheryl A. Lazarus; Alyson E. Mitchell; Ronald L. Prior; Guohua Cao; Pieter H. Jacobs; Bart G. Kremers; John F. Hammerstone; Robert B. Rucker; Karl A. Ritter; Harold H. Schmitz
The American Journal of Clinical Nutrition | 2001
Ying Wan; Joe A. Vinson; Terry D. Etherton; John Proch; Sheryl A. Lazarus; Penny M. Kris-Etherton
The American Journal of Clinical Nutrition | 2003
Laurent Rios; Marie-Paule Gonthier; Christian Rémésy; Isabelle Mila; Catherine Lapierre; Sheryl A. Lazarus; Gary Williamson; Augustin Scalbert
The American Journal of Clinical Nutrition | 2002
Laurent Rios; Richard N. Bennett; Sheryl A. Lazarus; Christian Rémésy; Augustin Scalbert; Gary Williamson
Journal of Agricultural and Food Chemistry | 1999
Sheryl A. Lazarus; Gary E. Adamson; John F. Hammerstone; Harold H. Schmitz